| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |